Insusense

CRO focused on drug discovery and development for diabetes and other metabolic diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2011 groups1 employees language insusense.com

Registered entities

Innovation

11 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 874 times.

YearFilings
20201
20212
20226
20237
20248

Investor mix

1 investor on record; lead investors include Lundbeck Foundation.

Investor typeCountShare
Private equity1100%
Coming soon